<< Sequoia Hospital completes 1000 atrial fibrillation ablation procedures | PDL BioPharma announces revenue guidance for the third quarter ended September 30, 2009 >>

Report on worldwide markets for lung cancer therapeutics

9. September 2009 05:56

Reportlinker.com announces that a new market research report is available in its catalogue: Lung Cancer Therapeutics

http://www.reportlinker.com/p0131247/Lung-Cancer-Therapeutics.html

This report analyzes the worldwide markets (Annual Revenues) for Lung Cancer Therapeutics in Millions of US$. The US market for Non-Small Cell Lung Cancer treatment is further analyzed by: Chemotherapy Drugs, and Targeted Drugs. The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual forecasts are provided for each region for the period 2005 through 2015. The report profiles 191 companies including many key and niche players worldwide such as AstraZeneca PLC., Bristol-Myers Squibb Co., Eli Lilly & Co., F. Hoffmann-La Roche Ltd., Genentech, Inc., GlaxoSmithKline Plc., Novartis Pharmaceuticals Corporation, OSI Pharmaceuticals, Inc., Sanofi-Aventis, AbGenomics International Inc., ImClone Systems, Inc., Pfizer, Inc., Merck Serono International S.A., Merck & Co. Ltd., Telik, Inc., and Woomera Therapeutics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Source: http://www.reportlinker.com

6f9034d8-b45c-4e32-b89b-4b1bec59f204|0|.0

Posted in: Medical Condition News

Tags: Abraxane, Alimta, Antibody, Avastin, Cancer, Carboplatin, Cediranib, Cell, Cetuximab, Chemotherapy, Cisplatin, Docetaxel, Erlotinib, Gefitinib, Gemcitabine, Iressa, Irinotecan, Lung Cancer, Monoclonal Antibody, Nexavar, Non-Small Cell Lung Cancer, Paclitaxel, Pfizer, Photodynamic Therapy, Small Cell Lung Cancer, Sorafenib, Sunitinib, Tarceva, Vaccine, Vandetanib, VEGF, Vinflunine, Vinorelbine, Xyotax, Zactima, Zolinza

FDA approves Istodax for treatment of Cutaneous T-cell LymphomaThe U.S. Food and Drug Administration has approved Istodax (romidepsin), an injectable medication, f...NHLBI grants for diagnosis and treatment of cardiovascular and blood disordersTwo teams led by Massachusetts General Hospital (MGH) researchers, also members of the Harvard Stem ...Promising results from Cell Therapeutics' phase II OPAXIO study for advanced esophageal cancerCell Therapeutics, Inc. announced today that, in a study from Brown University to be presented by Ho...PSA test vital for assessing prostate cancerWhen it comes to the prostate cancer, the disease known as the "silent killer" because it often exhi...Winners of Paul Marks Prize 2009Three young investigators who have taken significant steps toward advancing the understanding of can...Report on worldwide markets for lung cancer therapeuticsReportlinker.com announces that a new market research report is available in its catalogue: Lung Can...NIAID to establish a human immune profiling research consortium in 2010; invites grant applicationsThe National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Insti...New colon cancer targetNew research led by scientists at the University of North Carolina at Chapel Hill School of Medicine...Pharmathene reports Q2 2009 financialsPharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against ...Discovery of key molecular target in age-related macular degenerationA team of researchers led by Dr. Jayakrishna Ambati at the University of Kentucky has discovered a b...Gene that stops or suppress cancer plays a role in cancer stem cellsA gene well known to stop or suppress cancer plays a role in cancer stem cells, according to a new s...Abraxane prolongs survival in metastatic breast cancerResearch from the Northwestern University Feinberg School of Medicine has found that a less toxic, s...Trial of new combination treatment targeting hormone receptor-positive locally advanced breast cancerResearchers at The Cancer Institute of New Jersey (CINJ) have opened a clinical trial, which aims to...Twin nanoparticle targets then zaps breast cancer cellsBreast cancer patients face many horrors, including those that arise when fighting the cancer itself...Microchip-based device determines the genetic signature of lung tumorsMassachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based...New clinical trial for patients with asbestos-associated lung cancerThe Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyteria...Combining sorafenib with carboplatin/paclitaxel adds no benefit in lung cancerA clinical trial evaluating the benefit of adding the drug sorafenib to the combination of carboplat...Global Alliance for PharmacogenomicsLeaders at the National Institutes of Health and the Center for Genomic Medicine in Japan have signe...AstraZeneca completes enrollment in phase III studies of cancer drug vandetanibAstraZeneca has announced that it has completed patient enrollment in two pivotal Phase III studies ...How tumors respond to EGFR inhibitorsThree papers published this month in the open access general medical journal PLoS Medicine investiga...Cancer trial combines multiple drugs to attack blood vessel formation in patients with kidney cancerIn the first clinical trial of its kind, researchers at the University of Pennsylvania School of Med...Chemotherapy before surgery appears better than surgery alone for nonsmall cell lung cancerCombining pre-operative chemotherapy and surgery increases the average chance of survival at five ye...NewYork-Presbyterian and AstraZeneca collaborate in series of cancer studiesNewYork-Presbyterian Hospital is one of six centers nationally to be selected for collaboration with...Simple blood test detects lung cancer before it's too lateResearchers in the United States have developed a blood test that is able to correctly predict non-s...Sunitinib therapy shows promise in children with metastatic gastrointenstinal stromal tumorChildren with a rare digestive-tract cancer that is resistant to front-line therapy have benefited f...Photodynamic therapy lighting the way for medical treatmentsFor the millions of people who suffer from acne, sun damage or even worse, skin cancer, there is a l...One-day treatment with the anticancer drug carboplatin is as effective as radiotherapy for testicular cancerOne-day treatment with the anticancer drug carboplatin is as effective and less toxic than three wee...Double whammy of chemo plus surgery extends life for lung cancer patientsRecent research which has shown that chemotherapy can significantly lengthen life in many patients w...Whole-body positron emission tomography/computed tomography scans may help physicians identify malignant cancerous tumorsA team of researchers at Johns Hopkins Medical Institutions in Baltimore, Md., reports that whole-bo...Ceramide can be administered through the blood stream to target and kill cancer cellsA Penn State College of Medicine study shows for the first time in an animal model that ceramide, a ...Avastin available across Europe within the next few weeksRoche has announced that the European Commission has approved Avastin (bevacizumab, rhuMAb-VEGF), th...Key molecule helps identify renal cell carcinomaMayo Clinic researchers have discovered a key molecule that lets doctors identify one of the most ag...Call for FDA to address Viagra abuseOn August 5, 2004, the San Francisco Department of Public Health, STD Prevention Section, exercised ...Chemotherapy agents as well as the newest biologic and targeted cancer therapy drugs, can harm a patient’s heartCancer treatments, including the most commonly used chemotherapy agents as well as the newest biolog...

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment

Quirky Comment Title
Name*
E-mail* (Will show your Gravatar icon)
Country Country flag

b i u quote

Comment
Preview

Notify me when new comments are added

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Report on worldwide markets for lung cancer therapeutics

Recent Articles

Free!

Recent Comments

Twitter

Information

Report on worldwide markets for lung cancer therapeutics

Medical News Cloud

Recent Articles